tiprankstipranks
Trending News
More News >
Cytokinetics (CYTK)
NASDAQ:CYTK

Cytokinetics (CYTK) Revenue

Compare
1,066 Followers

Cytokinetics Revenue

Cytokinetics had a revenue of 1.58M in the quarter ending Mar 31, 2025, with -90.67%. This bring the company's revenue in the last twelve months to 19.22M, Decreased 4.03%. In the fiscal year ending Dec 31, 2024, Cytokinetics had annual revenue of 18.47M with 145.34% growth.
Revenue (ttm)
19.22M
Revenue Growth
412.21%
P/S Ratio
214.37
Revenue/Employee
$37,096
Employees
498
Market Cap
$3.96B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
18.47M10.94M+145.34%
Dec 31, 2023
7.53M-87.06M-92.04%
Dec 31, 2022
94.59M24.16M+34.30%
Dec 31, 2021
70.43M14.60M+26.15%
Dec 31, 2020
55.83M28.96M+107.79%
Dec 31, 2019
26.87M-4.63M-14.71%
Dec 31, 2018
31.50M18.13M+135.64%
Dec 31, 2017
13.37M-93.04M-87.44%
Dec 31, 2016
106.41M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis